Amble Tirzepatide (LY3298176) is a novel dual GIP and GLP-1 receptor agonist under development for the treatment of type 2 diabetes and obesity. As a leading manufacturer, we provide high purity Amble Tirzepatide for research purposes.
Our Amble Tirzepatide is produced under strict GMP conditions with comprehensive quality control. The product is supplied as lyophilized powder in sterile vials with purity guaranteed at ≥99% by HPLC analysis.
Key features of our Amble Tirzepatide include:
- High biological activity
- Excellent batch-to-batch consistency
- Comprehensive analytical documentation
- Stable under recommended storage conditions
This product is for research use only, not for human consumption. Proper laboratory handling procedures should be followed when working with this material.
We offer flexible packaging options including 5mg, 10mg and 20mg vials (10 vials per box). Custom synthesis and bulk quantities are available upon request.